NIIMBL, a public-private partnership sponsored by NIST, is accelerating innovation for biopharmaceutical manufacturing of lifesaving therapeutics. By solving industry challenges and developing a skilled workforce, NIIMBL drives U.S. competitiveness and economic security by advancing agile, world-leading manufacturing capabilities.
Website: NIIMBL.ORG
Established: 2017
Headquarters: Newark, DE
Consortium Organizer: University of Delaware
NIIMBL advances innovative platforms and technologies to enable faster, more flexible biopharmaceutical manufacturing production. Its collaborative ecosystem—comprising industry, academia, community colleges, and government partners—strengthens national economic security and increases agility in responding to public health emergencies, speeding patient access to life-saving medicines.
2026 NIIMBL National Meeting
Building a Shared AAV Manufacturing Resource: A Public Workshop
The 10th NIIMBL National Meeting will take place in Washington, D.C., from June 23-25, 2026
| Kelley Rogers | NIIMBL Federal Technical Program Officer | kelley.rogers [at] nist.gov (kelley[dot]rogers[at]nist[dot]gov) |
| Jorge Lamboy | NIIMBL Federal Technical Program Manager | jorge.lamboy [at] nist.gov (jorge[dot]lamboy[at]nist[dot]gov) |
| Christina Jones | NIIMBL Federal Education and Workforce Development Program Manager | christina.jones [at] nist.gov (christina[dot]jones[at]nist[dot]gov) |
| Adrienne Cheng | NIIMBL Federal Technical Program Manager | adrienne.cheng [at] nist.gov (adrienne[dot]cheng[at]nist[dot]gov) |
| Shelly Pollard | NIIMBL Federal Communications | shelly.pollard [at] nist.gov (shelly[dot]pollard[at]nist[dot]gov) |